Neuroimaging – News and Features

NCI’s Nanotechnology Characterization Laboratory selects Luna’s MRI contrast agent candidate for preclinical characterization.

Inherited variations in the amount of an innate anxiety-reducing molecule help explain why some people can withstand stress better than others, according to study.

NIH has announced the recipients of grants that will support studies covering a broad range of autism research areas.

Evotec’s EVT 101 shown to penetrate the brain in man and to modulate brain activity during the performance of cognitive tasks.

FluoroPharma signs licensing agreement with MGH for the development and commercialization of agents for diagnosis and treatment of Alzheimer's disease.

Definiens will now provide its key technology for high content image analysis and data management to MRI.

The collaboration focuses development of imaging and diagnostic technologies using genomics, proteomics, and integrated research and clinical care.

LabCorp enters into an exclusive license agreement to commercialize Duke's new blood-based assay for early detection of lung cancer.

In a study comparing brain activity of sober alcoholics and non-addicted people making financial decisions, the group of sober alcoholics showed more impulsive neural activity.

Multi-site clinical trial to study GM-I’s LumaGEM® Molecular Breast Imaging (MBI) technology for early detection, diagnosis and treatment of breast cancer.